AiCure
3 known investors
AiCure develops H.Code, an AI platform using computer vision, chat, and predictive analytics to verify and monitor medication adherence and clinical behavior in trial participants via smartphone. It serves pharmaceutical companies, CROs, and healthcare providers across the clinical trial lifecycle.
AI & Machine LearningDigital HealthHealthtech
Investors · 3
Frequently asked questions
- What does AiCure do?
- AiCure develops H.Code, an AI platform using computer vision, chat, and predictive analytics to verify and monitor medication adherence and clinical behavior in trial participants via smartphone. It serves pharmaceutical companies, CROs, and healthcare providers across the clinical trial lifecycle.
- Who are AiCure's investors?
- AiCure's investors include Accelmed Partners, Palisades Growth Capital, Tribeca Venture Partners.